
AstraZeneca has been dealt a blow by a key advisory committee to the US Food and Drug Administration, which has …
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical

